Steven Rosgen Net Worth

Steven Rosgen biography

Steven T. Rosgen serves as Independent Director of the Company. Mr. Rosgen joined the Board of Directors in January 2018 and the Audit Committee of the Board of Directors effective April 1, 2018. He is President of Strategem Research Inc., a company founded in 2005 to collect insights into buyers’ needs, aspirations and behaviors, and to use this knowledge to develop launch strategies for new technologies, and to revitalize products that have struggled in the market. Mr. Rosgen specializes in value proposition development and pricing strategy. He has worked with leading global agricultural companies in multiple sectors (ag informatics, biotechnology, crop protection, fertilizer, equipment, finance, grain marketing, livestock production, and seed technology). He has conducted thousands of face-to-face interviews with North American crop and livestock producers and has worked in markets around the world. Before founding Strategem, Mr. Rosgen was a senior partner with Street Smart Strategic Planning, Director of Marketing with Hosteling International, and Research Coordinator for Baker Lovick/BBDO Advertising. He holds a Bachelor of Commerce Degree from the University of Calgary.

How old is Steven Rosgen?

Steven Rosgen is 54, he's been the Independent Director of Immucell since 2018. There are 9 older and 1 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.

What's Steven Rosgen's mailing address?

Steven's mailing address filed with the SEC is C/O IMMUCELL CORPORATION,, 56 EVERGREEN DRIVE, PORTLAND,, ME, 04103.

Insiders trading at Immucell

Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin, and Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.

What does Immucell do?

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.

Immucell executives and stock owners

Immucell executives and other stock owners filed with the SEC include:

• Michael F. Brigham,
  Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director
• Michael Brigham,
  President, Chief Executive Officer, Treasurer, Secretary, Director
• Bobbi Brockmann,
  Vice President - Sales and Marketing, Director
• Elizabeth Williams,
  Vice President - Manufacturing Operations
• Elizabeth L. Williams,
  VP of Manufacturing Operations
• Dr. Joseph H. Crabb Ph.D.,
  VP & Chief Scientific Officer
• Joseph Crabb,
  Chief Scientific Officer, Vice President
• David Tomsche,
  Chairman of the Board
• Paul Wainman,
  Independent Director
• Jonathan Rothschild,
  Independent Director
• Steven Rosgen,
  Independent Director
• David Cunningham,
  Independent Director
• John W. Zinckgraf,
  Director of Product Devel.
• A. Gustavo Scaffa,
  Sr. Director of Quality
• Elizabeth S. Toothaker,
  Director of Fin. & Admin.
• Linda Rhodes,
  Director
• Brian L. Pessin,
  
• Norman H Pessin,
  
• Gloria F Basse,
  Director
• Anthony B Cashen,
  Director
• Robert C Bruce,
  Director
• William H Maxwell,
  Director
• Bryan K. Gathagan,